The epigenetic progenitor origin of human cancer (original) (raw)

• Pitot, H. C. Fundamentals of Oncology (Marcel Dekker, New York, 1986).
  Google Scholar
• Boveri, T. & Boveri, M. The Origin of Malignant Tumors (Williams and Wilkins, Baltimore, 1929).
  Google Scholar
• Sawyers, C. Targeted cancer therapy. Nature 432, 294–297 (2004).
  Article CAS PubMed Google Scholar
• Feinberg, A. P. & Tycko, B. The history of cancer epigenetics. Nature Rev. Cancer 4, 143–153 (2004).
  Article CAS Google Scholar
• Schmid, M., Haaf, T. & Grunert, D. 5-Azacytidine-induced undercondensations in human chromosomes. Hum. Genet. 67, 257–263 (1984).
  Article CAS PubMed Google Scholar
• Eden, A., Gaudet, F., Waghmare, A. & Jaenisch, R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455 (2003). A mouse DNA methyltransferase I knockout supports a causal role for global hypomethylation in cancer, which is mediated in part by increased recombination.
  Article CAS PubMed Google Scholar
• Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science 300, 489–492 (2003).
  Article CAS PubMed Google Scholar
• Holm, T. M. et al. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8, 275–285 (2005). A mouse transient DNA methyltransferase I knockout supports a causal role for loss of imprinting in cancer.
  Article CAS PubMed Google Scholar
• Nishigaki, M. et al. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res. 65, 2115–2124 (2005). A good example of CpG hypomethylation leading to oncogene activation.
  Article CAS PubMed Google Scholar
• Oshimo, Y. et al. Promoter methylation of cyclin D2 gene in gastric carcinoma. Int. J. Oncol. 23, 1663–1670 (2003).
  CAS PubMed Google Scholar
• Akiyama, Y., Maesawa, C., Ogasawara, S., Terashima, M. & Masuda, T. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am. J. Pathol. 163, 1911–1919 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Cho, M. et al. Activation of the MN/CA9 gene is associated with hypomethylation in human renal cell carcinoma cell lines. Mol. Carcinog. 27, 184–189 (2000).
  Article CAS PubMed Google Scholar
• Sato, N. et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res. 63, 4158–4166 (2003).
  CAS PubMed Google Scholar
• Sakai, T. et al. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet. 48, 880–888 (1991).
  CAS PubMed PubMed Central Google Scholar
• Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nature Rev. Genet. 3, 415–428 (2002).
  Article CAS PubMed Google Scholar
• Herman, J. G. & Baylin, S. B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042–2054 (2003).
  Article CAS PubMed Google Scholar
• Bjornsson, H. T., Fallin, M. D. & Feinberg, A. P. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 20, 350–358 (2004).
  Article CAS PubMed Google Scholar
• Nowell, P. C. The clonal nature of neoplasia. Cancer Cells 1, 29–30 (1989).
  CAS PubMed Google Scholar
• US National Cancer Advisory Board Working Group on Biomedical Technology. Recommendation for a Human Cancer Genome Project. Report to National Cancer Advisory Board [online], <http://deainfo.nci.nih.gov/Advisory/ncab/sub-bt/NCABReport_Feb05.pdf> (2005).
• Rowley, J. D. The Philadelphia chromosome translocation. A paradigm for understanding leukemia. Cancer 65, 2178–2184 (1990).
  Article CAS PubMed Google Scholar
• Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
  CAS PubMed Google Scholar
• de la Chapelle, A. Genetic predisposition to colorectal cancer. Nature Rev. Cancer 4, 769–780 (2004).
  Article CAS Google Scholar
• Kaelin, W. G. Jr. The von Hippel–Lindau tumor suppressor gene and kidney cancer. Clin. Cancer Res. 10, S6290—S6295 (2004).
  Article Google Scholar
• Druker, B. J. et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells. Nature Med. 2, 561–566 (1996).
  Article CAS PubMed Google Scholar
• Welm, A. L., Kim, S., Welm, B. E. & Bishop, J. M. MET and MYC cooperate in mammary tumorigenesis. Proc. Natl Acad. Sci. USA 102, 4324–4329 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, S. J. et al. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Clin. Cancer Res. 9, 5161–5170 (2003).
  CAS PubMed Google Scholar
• Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927–939 (2004).
  Article CAS PubMed Google Scholar
• Tachimori, A. et al. Up regulation of ICAM-1 gene expression inhibits tumour growth and liver metastasis in colorectal carcinoma. Eur. J. Cancer 41, 1802–1810 (2005).
  Article CAS PubMed Google Scholar
• Wang, T. L. et al. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc. Natl Acad. Sci. USA 99, 3076–3080 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Egger, G., Liang, G., Aparicio, A. & Jones, P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457–463 (2004).
  Article CAS PubMed Google Scholar
• Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
  Article CAS PubMed Google Scholar
• Brandeis, M. et al. Sp1 elements protect a CpG island from de novo methylation. Nature 371, 435–438 (1994).
  Article CAS PubMed Google Scholar
• Feinberg, A. P. & Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89–92 (1983). The first report that documents widespread hypomethylation in human cancer.
  Article CAS PubMed Google Scholar
• Goelz, S. E., Vogelstein, B., Hamilton, S. R. & Feinberg, A. P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228, 187–190 (1985).
  Article CAS PubMed Google Scholar
• Gama-Sosa, M. A. et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11, 6883–6894 (1983).
  Article CAS PubMed PubMed Central Google Scholar
• Greger, V. et al. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet. 94, 491–496 (1994).
  Article CAS PubMed Google Scholar
• Gonzalez-Zulueta, M. et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55, 4531–4535 (1995).
  CAS PubMed Google Scholar
• Herman, J. G. et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl Acad. Sci. USA 91, 9700–9704 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Hiltunen, M. O. et al. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int. J. Cancer 70, 644–648 (1997).
  Article CAS PubMed Google Scholar
• Suzuki, H. et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nature Genet. 36, 417–422 (2004).
  Article CAS PubMed Google Scholar
• Esteller, M., Corn, P. G., Baylin, S. B. & Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225–3229 (2001).
  CAS PubMed Google Scholar
• De Smet, C. et al. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl Acad. Sci. USA 93, 7149–7153 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Nakamura, N. & Takenaga, K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin. Exp. Metastasis 16, 471–479 (1998).
  Article CAS PubMed Google Scholar
• Wu, H. et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature (in the press).
• Yamada, Y. et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl Acad. Sci. USA 102, 13580–13585 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Cui, H. et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299, 1753–1755 (2003). The authors provide evidence that epigenetic change in normal cells is linked to increased risk of human cancer.
  Article CAS PubMed Google Scholar
• Sakatani, T. et al. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 307, 1976–1978 (2005). The authors use a mouse model to demonstrate the causal role of LOI and involvement of stem cells in predisposing to colon cancer.
  Article CAS PubMed Google Scholar
• Clark, S. J. & Melki, J. DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 21, 5380–5387 (2002).
  Article CAS PubMed Google Scholar
• Stirzaker, C., Song, J. Z., Davidson, B. & Clark, S. J. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 64, 3871–3877 (2004).
  Article CAS PubMed Google Scholar
• Mutskov, V. & Felsenfeld, G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J. 23, 138–149 (2004). This article shows that hypermethylation of promoters arises secondarily to transcriptional inactivation.
  Article CAS PubMed Google Scholar
• Wolffe, A. Chromatin: Structure and Function (Academic, San Diego, 1995).
  Google Scholar
• Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251–260 (1997).
  Article CAS PubMed Google Scholar
• Ringrose, L. & Paro, R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 38, 413–443 (2004).
  Article CAS PubMed Google Scholar
• Freitas, M. A., Sklenar, A. R. & Parthun, M. R. Application of mass spectrometry to the identification and quantification of histone post-translational modifications. J Cell Biochem 92, 691–700 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Brower-Toland, B. et al. Specific contributions of histone tails and their acetylation to the mechanical stability of nucleosomes. J Mol Biol 346, 135–46 (2005).
  Article CAS PubMed Google Scholar
• Lachner, M., O'Carroll, D., Rea, S., Mechtler, K. & Jenuwein, T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116–120 (2001).
  Article CAS PubMed Google Scholar
• Turner, B. M. Cellular memory and the histone code. Cell 111, 285–291 (2002).
  Article CAS PubMed Google Scholar
• Hess, J. L. Mechanisms of transformation by MLL. Crit. Rev. Eukaryot. Gene Expr. 14, 235–254 (2004).
  Article CAS PubMed Google Scholar
• Sellers, W. R. & Loda, M. The EZH2 polycomb transcriptional repressor — a marker or mover of metastatic prostate cancer? Cancer Cell 2, 349–350 (2002).
  Article CAS PubMed Google Scholar
• Fraga, M. F. et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nature Genet. 37, 391–400 (2005). The authors provide evidence that epigenome-wide changes, in particular histone modifications, are characteristic of nearly all tumours examined, revealing an unexpected connection between epigenetics and cancer.
  Article CAS PubMed Google Scholar
• Malik, H. S. & Henikoff, S. Phylogenomics of the nucleosome. Nature Struct. Biol. 10, 882–891 (2003).
  Article CAS PubMed Google Scholar
• Tomonaga, T. et al. Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer Res. 63, 3511–3516 (2003).
  CAS PubMed Google Scholar
• Feinberg, A. P. in The Genetic Basis of Human Cancer (eds Vogelstein, B. & Kinzler, K. W.) 43–55 (McGraw-Hill, New York, 2002).
  Google Scholar
• Ravenel, J. D. et al. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J. Natl Cancer Inst. 93, 1698–1703 (2001).
  Article CAS PubMed Google Scholar
• Woodson, K. et al. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J. Natl Cancer Inst. 96, 407–410 (2004).
  Article CAS PubMed Google Scholar
• Nakanishi, H. et al. Loss of imprinting of PEG1/MEST in lung cancer cell lines. Oncol. Rep. 12, 1273–1278 (2004).
  CAS PubMed Google Scholar
• Sato, N., Matsubayashi, H., Abe, T., Fukushima, N. & Goggins, M. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. Clin. Cancer Res. 11, 4681–4688 (2005).
  Article CAS PubMed Google Scholar
• Yu, Y. et al. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc. Natl Acad. Sci. USA 96, 214–219 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Kang, M. J. et al. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin. Cancer Res. 6, 1767–1771 (2000).
  CAS PubMed Google Scholar
• Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. & Reed, J. C. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82, 1820–1828 (1993).
  CAS PubMed Google Scholar
• Nakagawa, T. et al. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas. J. Urol. 173, 243–246 (2005).
  Article CAS PubMed Google Scholar
• Pardal, R., Clarke, M. F. & Morrison, S. J. Applying the principles of stem-cell biology to cancer. Nature Rev. Cancer 3, 895–902 (2003).
  Article CAS Google Scholar
• Issa, J. P. et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 7, 536–540 (1994).
  Article CAS PubMed Google Scholar
• Sachs, L. Hematopoietic growth and differentiation factors and the reversibility of malignancy: cell differentiation and by-passing of genetic defects in leukemia. Med. Oncol. Tumor Pharmacother. 3, 165–176 (1986).
  CAS PubMed Google Scholar
• Lotem, J. & Sachs, L. Epigenetics wins over genetics: induction of differentiation in tumor cells. Semin. Cancer Biol. 12, 339–346 (2002).
  Article CAS PubMed Google Scholar
• Yuspa, S. H. Molecular and cellular basis for tumor promotion in mouse skin. Princess Takamatsu Symp. 14, 315–326 (1983).
  CAS PubMed Google Scholar
• Lorincz, M. C., Schubeler, D., Hutchinson, S. R., Dickerson, D. R. & Groudine, M. DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation. Mol. Cell Biol. 22, 7572–7580 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Holst, C. R. et al. Methylation of _p16_INK4a promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63, 1596–1601 (2003). This paper demonstrates that epigenetic lesions, that is, DNA hypermethylation, in normal breast tissue, are common in healthy women.
  CAS PubMed Google Scholar
• Crawford, Y. G. et al. Histologically normal human mammary epithelia with silenced _p16_INK4a overexpress COX-2, promoting a premalignant program. Cancer Cell 5, 263–273 (2004).
  Article CAS PubMed Google Scholar
• Hochedlinger, K. et al. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev. 18, 1875–1885 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, C. F. et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121, 823–835 (2005).
  Article CAS PubMed Google Scholar
• Singh, S. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004). This paper demonstrates that a small subpopulation of stem cells in a brain tumour propagates the cancer phenotype when serially transmitted from mouse to mouse.
  Article CAS PubMed Google Scholar
• Zhu, Y. et al. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8, 119–130 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Michor, F. et al. Dynamics of chronic myeloid leukaemia. Nature 435, 1267–1270 (2005).
  Article CAS PubMed Google Scholar
• Ren, R. Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia. Nature Rev. Cancer 5, 172–183 (2005).
  Article CAS Google Scholar
• Maitra, A. et al. Genomic alterations in cultured human embryonic stem cells. Nature Genet. 37, 1099–1103 (2005).
  Article CAS PubMed Google Scholar
• Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R. & Feinberg, A. P. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nature Med. 4, 1276–1280 (1998).
  Article CAS PubMed Google Scholar
• Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999).
  CAS PubMed Google Scholar
• Karhadkar, S. S. et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 707–712 (2004).
  Article CAS PubMed Google Scholar
• Schreiber, S. L. & Bernstein, B. E. Signaling network model of chromatin. Cell 111, 771–778 (2002).
  Article CAS PubMed Google Scholar
• Li, E., Bestor, T. H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915–926 (1992).
  Article CAS PubMed Google Scholar
• Pham, P., Bransteitter, R. & Goodman, M. F. Reward versus risk: DNA cytidine deaminases triggering immunity and disease. Biochemistry 44, 2703–2715 (2005).
  Article CAS PubMed Google Scholar
• Beale, R. C. et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J. Mol. Biol. 337, 585–596 (2004).
  Article CAS PubMed Google Scholar
• Okazaki, I. M. et al. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197, 1173–1181 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341–346 (2001).
  Article CAS PubMed Google Scholar
• Nussenzweig, M. C. & Alt, F. W. Antibody diversity: one enzyme to rule them all. Nature Med. 10, 1304–1305 (2004).
  Article CAS PubMed Google Scholar
• Petersen-Mahrt, S. DNA deamination in immunity. Immunol. Rev. 203, 80–97 (2005). This article points out that the similarity between the range in mutations of APOBEC-class deaminases and of gatekeeper mutations in cancer indicates that misregulation of these enzymes has a causal role in cancer.
  Article CAS PubMed Google Scholar
• Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379–391 (1998).
  Article CAS PubMed Google Scholar
• Hanna, L. A., Foreman, R. K., Tarasenko, I. A., Kessler, D. S. & Labosky, P. A. Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev. 16, 2650–2661 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643–655 (2003).
  Article CAS PubMed Google Scholar
• Ezeh, U. I., Turek, P. J., Reijo, R. A. & Clark, A. T. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104, 2255–2265 (2005).
  Article CAS PubMed Google Scholar
• Monk, M. & Holding, C. Human embryonic genes re-expressed in cancer cells. Oncogene 20, 8085–8091 (2001). This paper describes how genes that encode stemness functions are often overexpressed in human tumours.
  Article CAS PubMed Google Scholar
• Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624–629 (2002). The authors propose a potential mechanism for epigenetic silencing in cancer that does not directly involve DNA methylation.
  Article CAS PubMed Google Scholar
• Cha, T. L. et al. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 310, 306–310 (2005).
  Article CAS PubMed Google Scholar
• Yoshiura, K. et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl Acad. Sci. USA 92, 7416–7419 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Rattis, F. M., Voermans, C. & Reya, T. Wnt signaling in the stem cell niche. Curr. Opin. Hematol. 11, 88–94 (2004).
  Article CAS PubMed Google Scholar
• Ruiz i Altaba, A., Sanchez, P. & Dahmane, N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nature Rev. Cancer 2, 361–372 (2002).
  Article CAS Google Scholar
• Sapienza, C. Imprinted gene expression, transplantation medicine, and the 'other' human embryonic stem cell. Proc. Natl Acad. Sci. USA 99, 10243–10245 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Sancho, E., Batlle, E. & Clevers, H. Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol. 20, 695–723 (2004).
  Article CAS PubMed Google Scholar
• Yamashita, Y., Jones, D. & Fuller, M. Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome. Science 301, 1547–1550 (2003).
  Article CAS PubMed Google Scholar
• Hirohashi, S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153, 333–339 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Singal, R., Tu, Z. J., Vanwert, J. M., Ginder, G. D. & Kiang, D. T. Modulation of the connexin26 tumor suppressor gene expression through methylation in human mammary epithelial cell lines. Anticancer Res. 20, 59–64 (2000).
  CAS PubMed Google Scholar
• Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177–183 (2004).
  Article CAS Google Scholar
• Fearon, E. R. in The Genetic Basis of Human Cancer (eds Vogelstein, B. & Kinzler, K. W.) 197–206 (McGraw-Hill, New York, 2002).
  Google Scholar
• Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643–649 (1998).
  Article CAS PubMed Google Scholar
• Ohlsson, R. et al. Epigenetic variability and the evolution of human cancer. Adv. Cancer Res. 88, 145–168 (2003).
  Article CAS PubMed Google Scholar
• Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
  Article CAS PubMed Google Scholar
• Sharpless, N. E. & DePinho, R. A. Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. 113, 160–168 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Tanaka, H., Bergstrom, D. A., Yao, M. C. & Tapscott, S. J. Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification. Nature Genet. 37, 320–327 (2005).
  Article CAS PubMed Google Scholar
• Tomonaga, T. et al. Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy. Cancer Res. 65, 4683–4689 (2005). The authors show that experimental misregulation of a centromere protein causes aneuploidy, indicating that the common elevation of centromere proteins in cancer underlies chromosome instability seen in cancer.
  Article CAS PubMed Google Scholar
• Kirschmann, D. A. et al. Down-regulation of HP1Hsα expression is associated with the metastatic phenotype in breast cancer. Cancer Res. 60, 3359–3363 (2000).
  CAS PubMed Google Scholar
• Kuzmichev, A., Jenuwein, T., Tempst, P. & Reinberg, D. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol. Cell 14, 183–193 (2004).
  Article CAS PubMed Google Scholar
• Rutherford, S. L. & Lindquist, S. Hsp90 as a capacitor for morphological evolution. Nature 396, 336–342 (1998).
  Article CAS PubMed Google Scholar
• Rutherford, S. L. & Henikoff, S. Quantitative epigenetics. Nature Genet. 33, 6–8 (2003).
  Article CAS PubMed Google Scholar
• Sollars, V. et al. Evidence for an epigenetic mechanism by which HSP90 acts as a capacitor for morphological evolution. Nature Genet. 33, 70–74 (2003). The authors use a sensitive phenotypic assay to show that when the chaperone protein Hsp90 is mutated or inhibited, highly inbred flies show unexpected epigenetic variation.
  Article CAS PubMed Google Scholar
• Berenblum, I. in General Pathology (ed. Florey, H.) (Saunders, Philadelphia, 1962).
  Google Scholar
• Klein, G. Epigenetics: surveillance team against cancer. Nature 434, 150 (2005).
  Article CAS PubMed Google Scholar
• Wilson, M. J., Shivapurkar, N. & Poirier, L. A. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. Biochem. J. 218, 987–990 (1984). This is an early study showing that dietary methylation deficiency alone can cause cancer in animals.
  Article CAS PubMed PubMed Central Google Scholar
• Poirier, L. A. The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: an introduction. J. Nutr. 132, S2336–S2339 (2002).
  Article Google Scholar
• Pogribny, I. P. & James, S. J. De novo methylation of the _p16_INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats. Cancer Lett. 187, 69–75 (2002).
  Article CAS PubMed Google Scholar
• Giovannucci, E. et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J. Natl Cancer Inst. 85, 875–884 (1993).
  Article CAS PubMed Google Scholar
• Hamamoto, R. et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nature Cell Biol. 6, 731–740 (2004).
  Article CAS PubMed Google Scholar
• Ruden, D. M., Xiao, L., Garfinkel, M. D. & Lu, X. Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstibesterol on uterine development and cancer. Hum. Mol. Genet. 14, R149–R155 (2005).
  Article CAS PubMed Google Scholar
• Ohlsson, R. et al. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity. Cancer Res. 59, 3889–3892 (1999).
  CAS PubMed Google Scholar
• Miranti, C. K. & Brugge, J. S. Sensing the environment: a historical perspective on integrin signal transduction. Nature Cell Biol. 4, e83–e90 (2002).
  Article CAS PubMed Google Scholar
• Mueller, M. M. & Fusenig, N. E. Friends or foes — bipolar effects of the tumour stroma in cancer. Nature Rev. Cancer 4, 839–849 (2004).
  Article CAS Google Scholar
• Hendrix, M. J., Seftor, E. A., Hess, A. R. & Seftor, R. E. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nature Rev. Cancer 3, 411–421 (2003).
  Article CAS Google Scholar
• Fisher, B. et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N. Engl. J. Med. 328, 1581–1586 (1993).
  Article CAS PubMed Google Scholar
• Esteller, M. DNA methylation and cancer therapy: new developments and expectations. Curr. Opin. Oncol. 17, 55–60 (2005).
  Article CAS PubMed Google Scholar
• Jouvenot, Y. et al. Targeted regulation of imprinted genes by synthetic zinc-finger transcription factors. Gene Ther. 10, 513–522 (2003).
  Article CAS PubMed Google Scholar
• Poy, M. N. et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226–230 (2004).
  Article CAS PubMed Google Scholar
• Aaltonen, L. A. et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med. 338, 1481–1487 (1998).
  Article CAS PubMed Google Scholar
• Claus, E. B., Petruzella, S., Matloff, E. & Carter, D. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA 293, 964–969 (2005).
  Article CAS PubMed Google Scholar
• Luo, Z., Ronai, D. & Scharff, M. D. The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies. J. Allergy Clin. Immunol. 114, 726–735 (2004).
  Article CAS PubMed Google Scholar
• Garcia-Echeverria, C. et al. In vivo antitumor activity of NVP-AEW541 — A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 5, 231–239 (2004).
  Article CAS PubMed Google Scholar
• Hu M, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nature Genet. 37, 899–905 (2005).
  Article CAS PubMed Google Scholar